{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T20:24:03Z","timestamp":1773519843672,"version":"3.50.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.autrev.2015.01.004","type":"journal-article","created":{"date-parts":[[2015,1,17]],"date-time":"2015-01-17T00:50:00Z","timestamp":1421455800000},"page":"429-437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":49,"title":["Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease"],"prefix":"10.1016","volume":"14","author":[{"given":"Piero","family":"Ruscitti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Di Benedetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Ciccia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasiliki","family":"Liakouli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Carubbi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onorina","family":"Berardicurti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aroldo","family":"Rizzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Triolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Giacomelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2015.01.004_bb0005","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.berh.2008.08.006","article-title":"Adult-onset Still disease","volume":"22","author":"Fautrel","year":"2008","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.autrev.2015.01.004_bb0010","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jaut.2014.01.011","article-title":"Diagnosis and classification of adult Still's disease","volume":"48\u201349","author":"Mahroum","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2015.01.004_bb0015","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/RHU.0b013e3181b57199","article-title":"Liver abnormalities in adult onset Still's disease: a retrospective study of 77 Chinese patients","volume":"15","author":"Zhu","year":"2009","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.autrev.2015.01.004_bb0020","doi-asserted-by":"crossref","first-page":"156890","DOI":"10.1155\/2012\/156890","article-title":"IL-18 serum level in adult onset Still's disease: a marker of disease activity","volume":"2012","author":"Colafrancesco","year":"2012","journal-title":"Int J Inflamm"},{"key":"10.1016\/j.autrev.2015.01.004_bb0025","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.autrev.2014.08.032","article-title":"Adult onset Still's disease (AOSD) in the era of biologic therapies: dichotomous view for cytokine and clinical expressions","volume":"13","author":"Maria","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.01.004_bb0030","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10067-014-2487-4","article-title":"Life-threatening complications of adult-onset Still's disease","volume":"33","author":"Efthimiou","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2015.01.004_bb0035","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S0140-6736(87)90204-2","article-title":"Increased serum ferritin levels in adult Still's disease","volume":"1","author":"Ota","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2015.01.004_bb0040","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1297-319X(02)00409-8","article-title":"Ferritin levels in adult Still's disease: any sugar?","volume":"69","author":"Fautrel","year":"2002","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.autrev.2015.01.004_bb0045","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1182\/blood-2009-11-253815","article-title":"Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway","volume":"116","author":"Cohen","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2015.01.004_bb0050","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.1182\/blood.V99.10.3505","article-title":"Regulation of ferritin genes and protein","volume":"99","author":"Torti","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2015.01.004_bb0055","first-page":"760","article-title":"Serum ferritin: past, present and future","volume":"2010","author":"Wang","year":"1800","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.autrev.2015.01.004_bb0060","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jaut.2007.11.003","article-title":"New functions for an iron storage protein: the role of ferritin in immunity and autoimmunity","volume":"30","author":"Recalcati","year":"2008","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2015.01.004_bb0065","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nri1111","article-title":"The TIM gene family: emerging roles in immunity and disease","volume":"3","author":"Kuchroo","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.autrev.2015.01.004_bb0070","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1084\/jem.20050308","article-title":"Tim-2 regulates T helper type 2 responses and autoimmunity","volume":"202","author":"Chakravarti","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2015.01.004_bb0075","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.4049\/jimmunol.177.8.4966","article-title":"Cutting edge: inhibition of T cell activation by TIM-2","volume":"177","author":"Knickelbein","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2015.01.004_bb0080","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2172-12-30","article-title":"Expression of neuroimmune semaphorins 4A and 4D and their receptors in the lung is enhanced by allergen and vascular endothelial growth factor","volume":"12","author":"Smith","year":"2011","journal-title":"BMC Immunol"},{"key":"10.1016\/j.autrev.2015.01.004_bb0085","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1600-065X.2009.00772.x","article-title":"The costimulatory role of TIM molecules","volume":"229","author":"Rodriguez-Manzanet","year":"2009","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2015.01.004_bb0090","first-page":"2422","article-title":"Serum cytokine profiles in patients with adult onset Still's disease","volume":"30","author":"Choi","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2015.01.004_bb0095","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.autrev.2014.01.058","article-title":"Adult-onset Still's disease","volume":"13","author":"Gerfaud-Valentin","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"9927","key":"10.1016\/j.autrev.2015.01.004_bb0100","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(13)61048-X","article-title":"Adult haemophagocytic syndrome","volume":"383","author":"Ramos-Casals","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2015.01.004_bb0105","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.autrev.2007.01.016","article-title":"Ferritin in autoimmune diseases","volume":"6","author":"Zandman-Goddard","year":"2007","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.autrev.2015.01.004_bb0110","first-page":"RA27","article-title":"Macrophage activation syndrome: a frequent but under-diagnosed complication associated with rheumatic diseases","volume":"14","author":"Tristano","year":"2008","journal-title":"Med Sci Monit"},{"key":"10.1016\/j.autrev.2015.01.004_bb0115","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1136\/adc.85.5.421","article-title":"Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders","volume":"85","author":"Sawhney","year":"2001","journal-title":"Arch Dis Child"},{"issue":"4","key":"10.1016\/j.autrev.2015.01.004_bb0120","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.autrev.2007.11.025","article-title":"Macrophage activation syndrome in rheumatic disease: what is the role of the antigen presenting cell?","volume":"7","author":"Behrens","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2015.01.004_bb0130","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1182\/asheducation-2013.1.605","article-title":"Hemophagocytic lymphohistiocytosis: pathogenesis and treatment","volume":"2013","author":"Janka","year":"2013","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.autrev.2015.01.004_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2014.03.002","article-title":"Hemophagocytic syndromes \u2014 an update","author":"Janka","year":"2014","journal-title":"Blood Rev"},{"key":"10.1016\/j.autrev.2015.01.004_bb0140","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/ar3843","article-title":"Recent advances in the diagnosis and treatment of hemophagocytic lymphohistiocytosis","volume":"14","author":"Bode","year":"2012","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2015.01.004_bb0145","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/1741-7015-11-185","article-title":"The hyperferritinemic syndrome: macrophage activation syndrome, Still's disease, septic shock and catastrophic antiphospholipid syndrome","volume":"11","author":"Ros\u00e1rio","year":"2013","journal-title":"BMC Med"},{"issue":"10","key":"10.1016\/j.autrev.2015.01.004_bb0150","first-page":"662","article-title":"The hyperferritinemic syndromes and CD163: a marker of macrophage activation","volume":"16","author":"Colafrancesco","year":"2014","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.autrev.2015.01.004_bb0155","first-page":"424","article-title":"Preliminary criteria for classification of adult Still's disease","volume":"19","author":"Yamaguchi","year":"1992","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2015.01.004_bb0160","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1182\/asheducation-2009.1.127","article-title":"Hemophagocytic lymphohistiocytosis (HLH) and related disorders","author":"Filipovich","year":"2009","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"10.1016\/j.autrev.2015.01.004_bb0165","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1111\/imj.12002","article-title":"Successful treatment of macrophage activation syndrome complicating adult Still disease with anakinra","volume":"42","author":"Loh","year":"2012","journal-title":"Intern Med J"},{"key":"10.1016\/j.autrev.2015.01.004_bb0170","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3109\/s10165-010-0348-9","article-title":"Benefit and a possible risk of tocilizumab therapy for adult-onset Still's disease accompanied by macrophage-activation syndrome","volume":"21","author":"Kobayashi","year":"2011","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2015.01.004_bb0175","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/acr.20319","article-title":"Tocilizumab in refractory adult Still's disease","volume":"63","author":"Pu\u00e9chal","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/j.autrev.2015.01.004_bb0180","article-title":"Adult-onset Still's disease: from pathophysiology to targeted therapies","volume":"879020","author":"Mavragani","year":"2012","journal-title":"Int J Inflamm"},{"key":"10.1016\/j.autrev.2015.01.004_bb0185","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10067-013-2381-5","article-title":"Tocilizumab for the treatment of adult-onset Still's disease: results from a case series","volume":"33","author":"Cipriani","year":"2014","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2015.01.004_bb0190","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1084\/jem.20050473","article-title":"Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade","volume":"201","author":"Pascual","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2015.01.004_bb0195","first-page":"2189","article-title":"Proinflammatory cytokine profiles in sera and pathological tissues of patients with active untreated adult onset Still's disease","volume":"31","author":"Chen","year":"2004","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2015.01.004_bb0200","doi-asserted-by":"crossref","first-page":"967","DOI":"10.3899\/jrheum.090662","article-title":"Cytokine profiles of macrophage activation syndrome associated with rheumatic diseases","volume":"37","author":"Maruyama","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2015.01.004_bb0205","doi-asserted-by":"crossref","first-page":"12638","DOI":"10.1016\/S0021-9258(18)37801-3","article-title":"The molecular cloning and characterization of murine ferritin heavy chain, a tumor necrosis factor-inducible gene","volume":"263","author":"Torti","year":"1988","journal-title":"J Biol Chem"},{"issue":"2 Pt 1","key":"10.1016\/j.autrev.2015.01.004_bb0210","first-page":"L257","article-title":"Effects of TNF-alpha and IL-1beta on iron metabolism by A549 cells and influence on cytotoxicity","volume":"277","author":"Smirnov","year":"1999","journal-title":"Am J Physiol"},{"key":"10.1016\/j.autrev.2015.01.004_bb0215","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0006-291X(90)91466-6","article-title":"Interleukin 1 induces ferritin heavy chain in human muscle cells","volume":"169","author":"Wei","year":"1990","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.autrev.2015.01.004_bb0220","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0167-4889(00)00066-5","article-title":"Interleukin-1beta increases binding of the iron regulatory protein and the synthesis of ferritin by increasing the labile iron pool","volume":"1497","author":"Pi\u00f1ero","year":"2000","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.autrev.2015.01.004_bb0225","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/ni.2060","article-title":"Inflammation meets cancer, with NF-\u03baB as the matchmaker","volume":"12","author":"Ben-Neriah","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2015.01.004_bb0230","doi-asserted-by":"crossref","first-page":"956","DOI":"10.3324\/haematol.2013.085217","article-title":"Clinical and genetic predictors of prognosis in myelodysplastic syndromes","volume":"99","author":"Bejar","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.autrev.2015.01.004_bb0235","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2015.01.004_bb0240","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1084\/jem.20102538","article-title":"Hemophagocytosis causes a consumptive anemia of inflammation","volume":"208","author":"Zoller","year":"2011","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2015.01.004_bb0245","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MD.0000000000000021","article-title":"Adult-onset still disease: manifestations, treatment, outcome, and prognostic factors in 57 patients","volume":"93","author":"Gerfaud-Valentin","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2015.01.004_bb0250","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00005792-199103000-00004","article-title":"Adult Still's disease: manifestations, disease course, and outcome in 62 patients","volume":"70","author":"Pouchot","year":"1991","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.autrev.2015.01.004_bb0255","first-page":"197","article-title":"Report of 122 children from the International Registry. FHL Study Group of the Histiocyte Society","volume":"10","author":"Aric\u00f2","year":"1996","journal-title":"Leukemia"},{"key":"10.1016\/j.autrev.2015.01.004_bb0260","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1136\/ard.2005.046904","article-title":"Reactive haemophagocytic syndrome in adult-onset Still's disease: a report of six patients and a review of the literature","volume":"65","author":"Arlet","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2015.01.004_bb0265","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s10067-006-0238-x","article-title":"Hemophagocytic syndrome in one patient with adult-onset Still's disease. Presentation with febrile neutropenia","volume":"26","author":"Pamuk","year":"2007","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.autrev.2015.01.004_bb0270","first-page":"635","article-title":"Macrophage activation syndrome associated with etanercept in a child with systemic onset juvenile idiopathic arthritis","volume":"11","author":"Nadia","year":"2009","journal-title":"IMAJ"},{"key":"10.1016\/j.autrev.2015.01.004_bb0275","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00124743-200108000-00013","article-title":"Worsening of macrophage activation syndrome in a patient with adult onset Still's disease after initiation of etanercept therapy","volume":"7","author":"Stern","year":"2001","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.autrev.2015.01.004_bb0280","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/jcp.21009","article-title":"Ferritin \u2014 a mediator of apoptosis?","volume":"212","author":"Bresgen","year":"2007","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.autrev.2015.01.004_bb0285","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1093\/rheumatology\/keq397","article-title":"Markedly increased IL-18 liver expression in adult-onset Still's disease-related hepatitis","volume":"50","author":"Priori","year":"2011","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2015.01.004_bb0290","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.blre.2008.08.001","article-title":"Ferritin for the clinician","volume":"23","author":"Knovich","year":"2009","journal-title":"Blood Rev"},{"key":"10.1016\/j.autrev.2015.01.004_bb0295","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1084\/jem.20042433","article-title":"TIM-2 is expressed on B cells and in liver and kidney and is a receptor for H-ferritin endocytosis","volume":"202","author":"Chen","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2015.01.004_bb0300","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s12026-014-8563-7","article-title":"sCD163 in AOSD: a biomarker for macrophage activation related to hyperferritinemia","volume":"60","author":"Colafrancesco","year":"2014","journal-title":"Immunol Res"},{"key":"10.1016\/j.autrev.2015.01.004_bb0305","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1093\/rheumatology\/36.5.608","article-title":"Very high serum ferritin levels in adult-onset Still's disease","volume":"36","author":"Akritidis","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.autrev.2015.01.004_bb0310","first-page":"201","article-title":"Ferritin levels and response to treatment in patients with adult Still's disease","volume":"23","author":"Akritidis","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2015.01.004_bb0315","doi-asserted-by":"crossref","first-page":"156","DOI":"10.3899\/jrheum.080537","article-title":"The mid-range of the adjusted level of ferritin can predict the chronic course in patients with adult onset Still's disease","volume":"36","author":"Lee","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2015.01.004_bb0320","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/acr.22194","article-title":"Clinical manifestations of adult-onset Still's disease presenting with erosive arthritis: association with low levels of ferritin and interleukin-18","volume":"66","author":"Ichida","year":"2014","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.autrev.2015.01.004_bb0325","first-page":"299","article-title":"Haemophagocytic syndromes in adults: current concepts and challenges ahead","volume":"135","author":"Emmenegger","year":"2005","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.autrev.2015.01.004_bb0330","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/pbc.22774","article-title":"Rate of decline of ferritin in patients with hemophagocytic lymphohistiocytosis as a prognostic variable for mortality","volume":"56","author":"Lin","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.autrev.2015.01.004_bb0335","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF02982007","article-title":"A clinical analysis of 52 adult patients with hemophagocytic syndrome: the prognostic significance of the underlying diseases","volume":"74","author":"Takahashi","year":"2001","journal-title":"Int J Hematol"},{"key":"10.1016\/j.autrev.2015.01.004_bb0340","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1365-2133.2009.09549.x","article-title":"Frequency, clinical features and prognosis of cutaneous manifestations in adult patients with reactive haemophagocytic syndrome","volume":"162","author":"Fardet","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2015.01.004_bb0345","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3899\/jrheum.080365","article-title":"Clinical features and prognosis of adult-onset Still's disease: 61 cases from China","volume":"36","author":"Zeng","year":"2009","journal-title":"J Rheumatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997215000166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997215000166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T23:11:02Z","timestamp":1651014662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997215000166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":68,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S1568997215000166"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2015.01.004","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2015.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}